Applications are now open for the i4i Product Development Awards (PDA), run by the National Institute for Health Research. The PDA support translational research and development of medical devices, in vitro diagnostics, and high-impact patient-focused digital health technologies.

Application Process

All competitions under the i4i programme have a two-stage application process – only those successful at Stage 1 will receive an invite to proceed to Stage 2. Stage 1 opened on 14th April and will close on 9th June, with applicants set to receive the results of their submission by 10th August. Then, Stage 2 will launch with a deadline of 28th September.

Eligibility Criteria

Firstly, all projects must have demonstrated proof of concept and have a clear pathway towards adoption and commercialisation. They should last between 24 and 36 months. Applications can be led by SMEs, NHS providers or higher education institutions. However, eligible collaborations must consist of at least two types of organisation from the above list. For example, an SME may work in collaboration with an NHS service provider. In addition, the lead organisation must be registered in England.

The following activities may be eligible for funding from the Product Development Awards:
  • Research and development of medical devices and in vitro diagnostic devices across all areas of existing or emerging healthcare need
  • Digital health technologies that fall under Tier 3 of the NICE Evidence Framework for Digital Health Technologies, and that are focused on patient outcomes and intended for ultimate NHS use
  • Artificial Intelligence (AI) technologies including Augmented or Ambient Intelligence, applied in areas of health and social care including health promotion and prevention, diagnosis and treatment
  • Product development required to enable a technology for clinical use
  • Research and development of techniques or technologies from a different industry sector, which could have a potential impact if applied in a healthcare setting
  • Feasibility studies if developing a technology from a sector other than health
  • Studies to provide data relating to safety and effectiveness of a device
  • Clinical utility studies
  • CE/UKCA marking and other regulatory requirements
  • Activities associated with the technology’s market access strategy
  • Training associated with the implementation of new technology

RedKnight’s team of grant funding consultants has over 50 years’ combined experience, accessing more than £50 million. If you’d like our help applying to the Product Development Awards, please get in touch.

Not the opportunity you’re looking for? You can find alternative competitions on our blog and in our free monthly newsletter.